Sensus Healthcare, Inc. SRTS
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -12.91% | -68.69% | -59.32% | -62.20% | -22.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -12.91% | -68.69% | -59.32% | -62.20% | -22.12% |
| Cost of Revenue | -35.10% | -65.53% | -39.77% | -48.96% | 15.89% |
| Gross Profit | 21.19% | -73.51% | -77.24% | -73.30% | -48.23% |
| SG&A Expenses | 9.76% | -15.85% | -14.45% | -17.18% | 20.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.45% | -40.92% | -29.46% | -28.69% | 28.72% |
| Operating Income | 36.98% | -63.66% | -64.70% | -282.39% | -271.84% |
| Income Before Tax | 38.02% | -74.03% | -71.93% | -253.02% | -235.79% |
| Income Tax Expenses | -- | 886.45% | -1,560.91% | -57.56% | -362.25% |
| Earnings from Continuing Operations | -58.32% | -743.68% | -2.10% | -304.85% | -177.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.32% | -743.68% | -2.10% | -304.85% | -177.61% |
| EBIT | 36.98% | -63.66% | -64.70% | -282.39% | -271.84% |
| EBITDA | 37.76% | -67.79% | -66.48% | -268.14% | -259.63% |
| EPS Basic | -56.92% | -737.01% | -1.33% | -305.07% | -177.69% |
| Normalized Basic EPS | 38.57% | -72.55% | -70.59% | -253.21% | -235.94% |
| EPS Diluted | -51.17% | -737.01% | 0.00% | -305.07% | -185.71% |
| Normalized Diluted EPS | 38.57% | -72.55% | -70.59% | -254.03% | -236.14% |
| Average Basic Shares Outstanding | 0.87% | 0.87% | 0.74% | -0.05% | -0.01% |
| Average Diluted Shares Outstanding | 0.87% | 0.87% | 0.74% | -0.70% | -0.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |